Ming Dong Zhou
Vorstandsvorsitzender bei Zensun (Shanghai) Sci & Tech Co., Ltd.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Xi Fu Liu | M | - |
Zensun (Shanghai) Sci & Tech Co., Ltd.
 Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China.
Zensun USA, Inc.
 Zensun USA, Inc. Pharmaceuticals: MajorHealth Technology Part of Zensun (Shanghai) Sci & Tech Co., Ltd., Zensun USA, Inc. is a company that manufactures bio-therapeutic products. The company is based in San Diego, CA. The company was founded by Xi Fu Liu. | 24 Jahre |
| Xin Yan Li | M | - |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China.
Zensun USA, Inc.
Zensun USA, Inc. Pharmaceuticals: MajorHealth Technology Part of Zensun (Shanghai) Sci & Tech Co., Ltd., Zensun USA, Inc. is a company that manufactures bio-therapeutic products. The company is based in San Diego, CA. The company was founded by Xi Fu Liu. | 17 Jahre |
| Jian Mei Gan | F | 64 |
Fudan University
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 10 Jahre |
| Kate Vilaychack-Rizzo | F | - |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China.
Zensun USA, Inc.
Zensun USA, Inc. Pharmaceuticals: MajorHealth Technology Part of Zensun (Shanghai) Sci & Tech Co., Ltd., Zensun USA, Inc. is a company that manufactures bio-therapeutic products. The company is based in San Diego, CA. The company was founded by Xi Fu Liu. | 10 Jahre |
| Zheng Gang Jiang | M | 45 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 16 Jahre |
| Jin Juan Shi | F | 48 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 5 Jahre |
| Wei Hu Fan | M | 80 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 5 Jahre |
| Ting Dai | F | 45 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 19 Jahre |
| Ting Fang Cao | F | 46 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 22 Jahre |
| Yi Wei | M | 75 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 5 Jahre |
| Zhe Wang | M | 35 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 6 Jahre |
| Xiu Hua Zhang | F | 49 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 22 Jahre |
| Xiao Long Zhang | M | 45 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 5 Jahre |
| Peng Fei Xu | M | 45 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 5 Jahre |
| Kun Yang | M | 49 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 5 Jahre |
| Chen Zhu Ge | M | 45 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 8 Jahre |
| Ming De Fan | M | 48 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 5 Jahre |
| Yacov Shamash | M | 74 |
The State University of New York
| 32 Jahre |
| Fu Yun Guo | F | 42 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 5 Jahre |
| Yan Jin | F | 46 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 9 Jahre |
| Hansen A. Yuan | M | 80 |
The State University of New York
| 34 Jahre |
| Ming Lin Li | M | - |
Zensun USA, Inc.
Zensun USA, Inc. Pharmaceuticals: MajorHealth Technology Part of Zensun (Shanghai) Sci & Tech Co., Ltd., Zensun USA, Inc. is a company that manufactures bio-therapeutic products. The company is based in San Diego, CA. The company was founded by Xi Fu Liu. | - |
| Guang Qian Zhao | M | 70 |
Fudan University
| 46 Jahre |
| Bhawanjit K. Brar | M | - |
Zensun USA, Inc.
Zensun USA, Inc. Pharmaceuticals: MajorHealth Technology Part of Zensun (Shanghai) Sci & Tech Co., Ltd., Zensun USA, Inc. is a company that manufactures bio-therapeutic products. The company is based in San Diego, CA. The company was founded by Xi Fu Liu. | - |
| Russell W. Bessette | M | - |
The State University of New York
| 35 Jahre |
| Xiao Long Liu | M | 67 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 9 Jahre |
| Bin Xi | M | - |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 23 Jahre |
| Mitchell H. Pally | M | - |
The State University of New York
| 35 Jahre |
| Wen Hong Jin | M | 74 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 11 Jahre |
| Xiao Yan Qin | M | 40 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 10 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Denise S. Hawkins | F | 54 |
The State University of New York
| 4 Jahre |
| Michael W. Williams | M | - |
The State University of New York
| 6 Jahre |
| Kui Chen | M | 73 |
Fudan University
The State University of New York
| 9 Jahre |
| Hong Chao Zhu | M | 65 |
Fudan University
| 16 Jahre |
| Chris Montclare | M | - |
The State University of New York
| 5 Jahre |
| Xiao Li Deng | M | 57 |
The State University of New York
| 4 Jahre |
| Feng Hong | M | 64 |
Fudan University
| 4 Jahre |
| Zhi Hong | M | 60 |
The State University of New York
Fudan University
| 8 Jahre |
| Richard J. Ablin | M | - |
The State University of New York
| 6 Jahre |
| Qiong Pan | F | 69 |
The State University of New York
| 4 Jahre |
| Dodi Prawira Amtar | M | 61 |
The State University of New York
| 1 Jahre |
| Si Yuan Le | M | - |
The State University of New York
| 5 Jahre |
| Ambuj Kumar Jain | M | - |
The State University of New York
| 3 Jahre |
| Phil Goldfarb | M | - |
The State University of New York
| 4 Jahre |
| Keith David Weigel | M | - |
The State University of New York
| 3 Jahre |
| Yvette Fitzgerald | F | - |
The State University of New York
| 4 Jahre |
| Robert Allen Papiri | M | 62 |
The State University of New York
| 3 Jahre |
| Clifford F. Perry | M | - |
The State University of New York
| 4 Jahre |
| Matthew Daly | M | - |
The State University of New York
| 4 Jahre |
| Craig Schorling | M | - |
The State University of New York
| 4 Jahre |
| Jeffrey Adam Dachis | M | 58 |
The State University of New York
| 3 Jahre |
| Steven Goldsmith | M | - |
The State University of New York
| 4 Jahre |
| Jay Lefkowicz | M | - |
The State University of New York
| 4 Jahre |
| Cynthia Ullrich | F | - |
The State University of New York
| 4 Jahre |
| Jack Senzon | M | - |
The State University of New York
| 2 Jahre |
| Liz Russell | F | - |
The State University of New York
| 4 Jahre |
| Bethany R. Smith | F | - |
The State University of New York
| 4 Jahre |
| D. Bruce Johnstone | M | - |
The State University of New York
| 6 Jahre |
| Nak-Il Sung | M | 64 |
The State University of New York
| 3 Jahre |
| King Hui Lim | M | 60 |
The State University of New York
| 4 Jahre |
| Mike A. Pietzak | M | - |
The State University of New York
| 4 Jahre |
| Steven J. Towell | M | - |
The State University of New York
| 4 Jahre |
| Deok-Soo Cho | M | 57 |
The State University of New York
| 4 Jahre |
| Guo Ping Zhao | M | 75 |
Fudan University
| 4 Jahre |
| Dan Cesta | M | - |
The State University of New York
| 1 Jahre |
| Ricardo A. Knight | M | - |
The State University of New York
| 3 Jahre |
| Richard Jay Perez | M | - |
The State University of New York
| 4 Jahre |
| David M. Privitera | M | - |
The State University of New York
| 4 Jahre |
| Rebecca M. Stafford | F | - |
The State University of New York
| 4 Jahre |
| Bruce Howard Geller | M | 55 |
The State University of New York
| 4 Jahre |
| Peter J. St. Denis | M | - |
The State University of New York
| 4 Jahre |
| Alan Pavese | M | - |
The State University of New York
| 4 Jahre |
| Michael Rindos | M | - |
The State University of New York
| 4 Jahre |
| Bin Lin | M | 65 |
Fudan University
| 4 Jahre |
| Mark Alan Lozina | M | - |
The State University of New York
| 4 Jahre |
| Terrence Robert Emde | M | - |
The State University of New York
| 4 Jahre |
| Jeffrey Alan Saeger | M | - |
The State University of New York
| 4 Jahre |
| Kenneth J. Yanneck | M | - |
The State University of New York
| 2 Jahre |
| John K. Schneider | M | - |
The State University of New York
| - |
| Gary R. Mottola | M | - |
The State University of New York
| 2 Jahre |
| Gang Yu | M | 58 |
The State University of New York
| 1 Jahre |
| Mark Carey Rosenthal | M | - |
The State University of New York
| 4 Jahre |
| Glen M. Gans | M | - |
The State University of New York
| 4 Jahre |
| Hong Zhang | M | - |
Fudan University
| 4 Jahre |
| Yvan-Claude J. Pierre | M | - |
The State University of New York
| 4 Jahre |
| Vincent Foley | M | - |
The State University of New York
| 4 Jahre |
| Christopher Cali | M | - |
The State University of New York
| 4 Jahre |
| Daniel F. Cullen | M | - |
The State University of New York
| 4 Jahre |
| Robert Scott Kaplan | M | - |
The State University of New York
| 4 Jahre |
| Kenneth Heitner | M | - |
The State University of New York
| 4 Jahre |
| Lloyd S. Harmetz | M | - |
The State University of New York
| 4 Jahre |
| Gail Katz Dukas | F | - |
The State University of New York
| 4 Jahre |
| Adam Lustig | M | - |
The State University of New York
| 4 Jahre |
| Michael Lin | M | - |
The State University of New York
| 7 Jahre |
| Michael Wright | M | - |
The State University of New York
| 3 Jahre |
| Timothy Kuniskis | M | 57 |
The State University of New York
| 4 Jahre |
| James F. Moyle | M | - |
The State University of New York
| 4 Jahre |
| John Sheehan | M | - |
The State University of New York
| 4 Jahre |
| Yustinus Yusuf Kusumah | M | 56 |
The State University of New York
| 2 Jahre |
| Hee-Jun Kim | M | 62 |
The State University of New York
| 2 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 74 | 74,00% |
| China | 31 | 31,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Ming Dong Zhou
- Persönliches Netzwerk